Oksana Lidke
Psychiatric/Mental Health · Battle Creek, MINPI 1427512425
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Teva Pharmaceuticals USA, Inc. accounts for 68.5% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $13,943 and has fallen 71.5% since, to $3,979 in 2025. Among psychiatric/mental health clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 475 payments — averaging $62.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$20K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Neurocrine Biosciences, Inc.$1K
- Indivior Inc.$660
- plus $3K from 17 others
What the payments were for
- Speaking & faculty fees$16,97257%
- Travel & lodging$2,1927%
- Food & beverage$10,57836%
- Education$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 61 | $20,423 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 78 | $1,679 |
| AbbVie | 86 | $1,539 |
| Otsuka America Pharmaceutical, Inc. | 44 | $1,362 |
| Neurocrine Biosciences, Inc. | 44 | $1,103 |
| Indivior Inc. | 35 | $660 |
| Axsome Therapeutics, Inc. | 13 | $621 |
| Johnson & Johnson | 20 | $564 |
| Corium, LLC | 18 | $359 |
| Lundbeck LLC | 28 | $333 |
| Alkermes, Inc. | 11 | $305 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $216 |
| E.r. Squibb & Sons, L.L.C. | 3 | $148 |
| AstraZeneca | 1 | $118 |
| Noven Therapeutics, LLC | 5 | $88 |
| Neos Therapeutics, LP | 4 | $71 |
| Supernus Pharmaceuticals, Inc. | 3 | $57 |
| Braeburn Inc. | 3 | $45 |
| Validus Pharmaceuticals LLC | 2 | $40 |
| OWP Pharmaceuticals, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UZEDY$18,437
- REXULTI$606
- INGREZZA$482
- VRAYLAR$479
- LYBALVI$479
- Auvelity$468
- CAPLYTA$339
- Austedo XR$244
- ABILIFY MAINTENA$243
- INVEGA SUSTENNA$124
- COBENFY$121
- AUSTEDO$120
- ABILIFY ASIMTUFII$118
- AIRSUPRA$118
- Azstarys$107
How this compares
$29,793 in reported general payments places this provider in the 95th percentile of 638 psychiatric/mental health providers in Michigan.
Other psychiatric/mental health in Battle Creek
- Duren GutierrezSouthfield$207K
- Tamlynn EvansTraverse City$78K
- Shiba NixonClarkston$60K
- Amy AmesClinton Township$43K
- Cody ShinavierClarkston$41K
- Jennifer Wims-MaddenPontiac$28K
- Jessica ShantzWarren$21K
- Gladys KimeliSaginaw$17K
- Cynthia MaiSaginaw$16K
- Aliya PasikRochester Hills$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.